Bivalirudin versus Heparin Monotherapy in Percutaneous Coronary Intervention Patients: a Comparison of Acute Adverse Outcomes and Long Term Mortality

被引：0
|
作者：
Ephrem, Georges
Kim, Michael C.
Jauhar, Rajiv
Meraj, Perwaiz M.
机构：
来源：
CIRCULATION | 2014年 / 130卷
关键词：
Anticoagulants; Percutaneous coronary intervention (PCI); Glycoprotein iib/iiia platelet inhibitors; Outcomes;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
13072
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Cost-Effectiveness of Targeting Patients Undergoing Percutaneous Coronary Intervention for Therapy With Bivalirudin Versus Heparin Monotherapy According to Predicted Risk of Bleeding
    Amin, Amit P.
    Marso, Steven P.
    Rao, Sunil V.
    Messenger, John
    Chan, Paul S.
    House, John
    Kennedy, Kevin
    Robertus, Katherine
    Cohen, David J.
    Mahoney, Elizabeth M.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2010, 3 (04): : 358 - U47
  • [42] Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudin
    Ramana, Ravi K.
    Lewis, Bruce E.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (03) : 493 - 505
  • [43] EFFECTIVENESS OF BIVALIRUDIN VERSUS UNFRACTIONATED HEPARIN DURING PERCUTANEOUS CORONARY INTERVENTION AMONG PATIENTS WITH ACUTE MYOCARDIAL INFARCTION IN THE UNITED STATES
    Secemsky, Eric Alexander
    Kirtane, Ajay
    Bangalore, Sripal
    Ferro, Enrico
    Wimmer, Neil
    Roe, Matthew
    Dai, Dadi
    Mauri, Laura
    Yeh, Robert
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 20 - 20
  • [44] A comparison of the effect of eptifibatide plus heparin versus bivalirudin on thrombin generation and clot lysis in patients undergoing a percutaneous coronary intervention
    Spiotta, LB
    Jacoski, MV
    White, MM
    Cholera, S
    Sims, K
    Jennings, LK
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 41A - 41A
  • [45] Bivalirudin versus heparin in patients treated with percutaneous coronary intervention: a meta-analysis of randomised trials
    Cassese, Salvatore
    Byrne, Robert A.
    Laugwitz, Karl-Ludwig
    Schunkert, Heribert
    Berger, Peter B.
    Kastrati, Adnan
    EUROINTERVENTION, 2015, 11 (02) : 196 - 203
  • [46] Comparison of Long-Term Outcomes in Men versus Women Undergoing Percutaneous Coronary Intervention
    Murphy, Alexandra C.
    Dinh, Diem
    Koshy, Anoop N.
    Lefkovits, Jeffrey
    Clark, David J.
    Zaman, Sarah
    Duffy, Stephen J.
    Brennan, Angela
    Reid, Christopher
    Yudi, Matias B.
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 153 : 1 - 8
  • [47] Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in high-bleeding-risk patients with acute coronary syndrome in contemporary practice
    Zhang, Yahao
    Zhang, Yanghui
    Liu, Zhiyu
    Zhang, Bin
    Liu, Guizhi
    Chen, Kui
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 130
  • [48] Effects of baseline and early acquired thrombocytopaenia on long-term mortality in patients undergoing percutaneous coronary intervention with bivalirudin
    Ali, Ziad A.
    Qureshi, Yasir H.
    Galougahi, Keyvan Karimi
    Poludasu, Shyam
    Roy, Swathi
    Krishnan, Prakash
    Zalewski, Adrian
    Shah, Zainab Z.
    Bhatti, Navdeep
    Kalapatapu, Kumar
    Mehran, Roxana
    Dangas, George
    Kini, Annapoorna S.
    Sharma, Samin K.
    EUROINTERVENTION, 2016, 11 (14) : E1627 - E1638
  • [49] META-ANALYSIS COMPARING BIVALIRUDIN VS HEPARIN-MONOTHERAPY ON ISCHEMIC AND BLEEDING OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION
    Bertrand, O. F.
    Jolly, S. S.
    Rao, S.
    Patel, T.
    Belle, L.
    Bernat, I.
    Parodi, G.
    Costerousse, O.
    Mann, T.
    CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (05) : S312 - S313
  • [50] Uric acid is associated with long-term adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention
    Tscharre, Maximilian
    Herman, Robert
    Rohla, Miklos
    Hauser, Christina
    Farhan, Serdar
    Freynhofer, Matthias K.
    Huber, Kurt
    Weiss, Thomas W.
    ATHEROSCLEROSIS, 2018, 270 : 173 - 179
12345